scispace - formally typeset
Search or ask a question

Showing papers by "Richard W. Leggett published in 2018"


Journal ArticleDOI
TL;DR: An overview of ongoing work on the Million Worker Study is presented, highlighting some of the key methods and progress so far as exemplified by the study of workers at the Mallinckrodt Chemical Works.
Abstract: The purpose of this paper is to present an overview of ongoing work on the Million Worker Study (MWS), highlighting some of the key methods and progress so far as exemplified by the study of workers at the Mallinckrodt Chemical Works (MCW). The MWS began nearly 25 y ago and continues in a stepwise fashion, evaluating one study cohort at a time. It includes workers from U.S. Department of Energy (DOE) Manhattan Project facilities, U.S. Nuclear Regulatory Commission (NRC) regulated nuclear power plants, industrial radiographers, U.S. Department of Defense (DoD) nuclear weapons test participants, and physicians and technologists working with medical radiation. The purpose is to fill the major gap in radiation protection and science: What is the risk when exposure is received gradually over time rather than briefly as for the atomic bomb survivors? Studies published or planned in 2018 include leukemia (and dosimetry) among atomic veterans, leukemia among nuclear power plant workers, mortality among workers at the MCW, and a comprehensive National Council on Radiation Protection and Measurements (NCRP) Report on dosimetry for the MWS. MCW has a singular place in history: the 40 tons (T) of uranium oxide produced at MCW were used by Enrico Fermi on 2 December 1942 to produce the first manmade sustained and controlled nuclear reaction, and the atomic age was born. Seventy-six years later, the authors followed the over 2,500 MCW workers for mortality and reconstructed dose from six sources of exposure: external gamma rays from the radioactive elements in pitchblende; medical x rays from occupationally required chest examinations; intakes of pitchblende (uranium, radium, and silica) measured by urine samples; radon breath analyses and dust surveys overseen by Robley Evans and Merril Eisenbud; occupational exposures received before and after employment at MCW; and cumulative radon concentrations and lung dose from the decay of radium in the work environment. The unique exposure reconstructions allow for multiple evaluations, including estimates of silica dust. The study results are relevant today. For example, NASA is interested that radium, deposited in the brain, releases high-LET alpha particles - the only human analogue, though limited, for high energy, high-Z particles (galactic cosmic rays) traveling through space that might affect astronauts on Mars missions. Don't discount the past; it's the prologue to the future!

37 citations


Journal ArticleDOI
TL;DR: Malinckrodt Chemical Works was the earliest uranium processing facility in the Manhattan Project, beginning in 1942, and comprehensive dosimetric approach follows methods outlined by the National Council on Radiation Protection Scientific Committee 6‐9 for the Million Worker Study.
Abstract: Mallinckrodt Chemical Works was the earliest uranium processing facility in the Manhattan Project, beginning in 1942. Even then, concern existed about possible health effects resulting from exposure to radiation and pitchblende dust. This concern was well founded as the facility processed Belgian Congo pitchblende ore that was up to 60% pure uranium with high U content and up to 100 mg of radium per ton. Workers were exposed to external gamma radiation plus internal radiation from inhalation and ingestion of pitchblende dust (uranium, radium, and silica). Multiple sources of exposure were available for organ dose reconstruction to a degree unique for an epidemiologic study. Personal film badge measures available from 1945 captured external exposures. Additional external exposure included 15,518 occupational medical x-rays and 210 radiation exposure records from other facilities outside of Mallinckrodt employment. Organ dose calculations considered organ-specific coefficients that account for photon energy and job-specific orientation of workers to the radiation source during processing. Intakes of uranium and radium were based on 39,451 uranium urine bioassays and 2,341 breath radon measurements, and International Commission on Radiological Protection (ICRP) Publication 68 biokinetic models were used to estimate organ-specific radiation absorbed dose. Estimates of exposure to airborne radon and its short-lived progeny were based on radon measurements in work areas where radium-containing materials were handled or stored, together with estimated exposure times in these areas based on job titles. Dose estimates for radon and its short-lived progeny were based on models and methods recently recommended in ICRP Publication 137. This comprehensive dosimetric approach follows methods outlined by the National Council on Radiation Protection Scientific Committee 6-9 for the Million Worker Study. Annual doses were calculated for six organs: lung, brain, heart, kidney, colon and red bone marrow. Evaluation and adjustment for individual cumulative measures of pitchblende dust inhalation were made for lung and kidney diseases.

29 citations


Journal ArticleDOI
TL;DR: This review summarizes the conclusions and recommendations of NCRP Report No. 178 with a concentration on and overview of the dosimetry and uncertainty approaches for the cohorts in the MPS, along with guidelines regarding the essential approaches used to estimate organ doses and their uncertainties within the framework of an epidemiologic study.
Abstract: Purpose Scientific Committee 6-9 was established by the National Council on Radiation Protection and Measurements (NCRP), charged to provide guidance in the derivation of organ doses and their uncertainty, and produced a report, NCRP Report No. 178, Deriving Organ Doses and their Uncertainty for Epidemiologic Studies with a focus on the Million Person Study of Low-Dose Radiation Health Effects (MPS). This review summarizes the conclusions and recommendations of NCRP Report No. 178, with a concentration on and overview of the dosimetry and uncertainty approaches for the cohorts in the MPS, along with guidelines regarding the essential approaches used to estimate organ doses and their uncertainties (from external and internal sources) within the framework of an epidemiologic study. Conclusions The success of the MPS is tied to the validity of the dose reconstruction approaches to provide realistic estimates of organ-specific radiation absorbed doses that are as accurate and precise as possible and to properly evaluate their accompanying uncertainties. The dosimetry aspects for the MPS are challenging in that they address diverse exposure scenarios for diverse occupational groups being studied over a period of up to 70 y. Specific dosimetric reconstruction issues differ among the varied exposed populations that are considered: atomic veterans, U.S. Department of Energy workers exposed to both penetrating radiation and intakes of radionuclides, nuclear power plant workers, medical radiation workers, and industrial radiographers. While a major source of radiation exposure to the study population comes from external gamma- or x-ray sources, for some of the study groups, there is also a meaningful component of radionuclide intakes that requires internal radiation dosimetry assessments.

20 citations


Journal ArticleDOI
TL;DR: A volumetric scaling methodology is presented to derive estimates of regional blood volumes in humans at ages younger than the reference adult to refine models of tissue elemental composition in computational human phantoms of both patients and exposed members of the general public.
Abstract: Estimates of regional blood volumes (BVs) in humans are needed in dosimetric models of radionuclides and radiopharmaceuticals that decay in the circulation to a significant extent. These values are also needed to refine models of tissue elemental composition in computational human phantoms of both patients and exposed members of the general public. The International Commission on Radiological Protection (ICRP) in its Publication 89 provides reference values for total blood content in the full series of their reference individuals, to include the male and female newborn, 1 year-old, 5 year-old, 10 year-old, 15 year-old, and adult. Furthermore, Publication 89 provides reference values for the percentage distribution of total blood volume in 27 different blood-filled organs and tissues of the reference adult male and adult female. However, no similar distribution values are provided for non-adults. The goal of the present study is to present a volumetric scaling methodology to derive these values for the same organs and tissues at ages younger than the reference adult. Literature data on organ-specific vascular growth in the brain, kidneys, and skeletal tissues are also considered.

18 citations


Journal ArticleDOI
TL;DR: A method has been developed to identify and quantify the primary contaminants using high resolution gamma spectroscopy and VRF, a new spectrum analysis tool, and calculate specific organ and effective dose coefficients using ICRP Publication 103 tissue weighting factors.
Abstract: Oxygenated target waters of cyclotron targets contain long-lived contaminants due to (p,n) reactions in the HAVAR target window that are spalled into the target water. These contaminants are largely removed during the synthesis of the final imaging agent. Currently the USP requires that the final drug product be 99.5% pure, so the total activity of the long-lived contaminants can be no more than 0.5% of the final radiopharmaceutical product. A method has been developed to identify and quantify the primary contaminants using high resolution gamma spectroscopy and VRF, a new spectrum analysis tool. Uptake, retention, and excretion functions for each of the contaminating isotopes in a soluble, injected chemical form have also been calculated using International Commission on Radiological Protection (ICRP) Publication 123 models and are presented in the Appendices A and B of Electronic Supplementary Material. In addition, specific organ and effective dose coefficients were also calculated using ICRP Publication 103 tissue weighting factors and are also presented in the Appendices A and B of Electronic Supplementary Material. Typical imaging agents have contaminant loads far below the USP limit and contribute negligible doses to the patients receiving the drugs.

4 citations


Journal ArticleDOI
TL;DR: This work modeled a typical homeland security portal monitor in MCNP, and determined its sensitivity to each of the possible contaminating isotopes found in PET radiopharmaceuticals when distributed in patient phantoms to identify the isotopes that can cause alarms for substantial periods of time after the short-lived imaging agent has decayed away.
Abstract: In the USA during 2015 over 1,718,500 clinical PET scans were performed in 2380 centers. Patients undergoing these studies will alarm homeland security monitors at borders, ports, and some airports for up to 2 days due to the positron-annihilation photons (0.511 MeV) from the imaging isotope 18F (110 min half-life). In some radiopharmaceuticals, long-lived contaminants generated from the activation and spallation of elements in the HAVAR window of the cyclotron target may also be present in the patient dose. In this work, we have modeled a typical homeland security portal monitor in MCNP, and determined its sensitivity to each of the possible contaminating isotopes found in PET radiopharmaceuticals when distributed in patient phantoms. These data were combined with the time-dependent uptake/retention functions for the contaminating isotopes, to identify the isotopes that can cause alarms for substantial periods of time after the short-lived imaging agent has decayed away.

3 citations